Working in healthcare means no two days are ever the same! Policies, procedures, and payment models shift as new technology is developed, as new politicians and federal agency leaders come and go and as we learn how to increase efficiencies…

In today’s healthcare industry, patient outcomes and healthcare system success rely largely on analytics, and selecting the right technology for your organization can make all the difference. However, one often overlooked consideration when…

As we move into summer, the nation is cautiously reopening to varying degrees and we’re all finding our “new normal,” in a post-COVID-19 world, complete with face masks and social distancing. HRSA has released some new FAQs that will increase…

In early June, HRSA quietly updated several FAQs on its website and its contractor for the 340B Prime Vendor Program. One of the new questions that was added could make a big difference to covered entities in terms of 340B eligibility for offsite…

Across the country, health systems of all sizes and complexities use Sentry’s Sentinel® and Sentrex® platforms to manage and optimize participation in the 340B program. The key to successful program compliance is consistent integrity of…

The changes in our lives due to COVID-19 have been plentiful. We now get groceries delivered to our homes, wear face masks as standard fashion and have traded suits and heels for sweats and sneakers. One big adjustment for the healthcare industry…

As states across the US begin to cautiously look towards re-opening and many hospitals’ ICU capacities level out and elective surgeries resume, the wheels of progress keep turning. This month, we look at what the federal government is doing…

Federally Qualified Health Centers (FQHCs) operate on a not-for-profit basis and serve a disproportionate share of our nation’s vulnerable population – patients who often struggle with interconnected disparities that affect their health,…

CMS addresses 340B duplicate discounts Under the provisions of the 340B law, pharmaceutical manufacturers are not required to offer a drug at the 340B discount rate to covered entities and pay rebates to state Medicaid programs for the same…